nafoxidine has been researched along with Brain Neoplasms in 1 studies
Nafoxidine: An estrogen antagonist that has been used in the treatment of breast cancer.
Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, YS | 1 |
| Wurster, RD | 1 |
1 other study available for nafoxidine and Brain Neoplasms
| Article | Year |
|---|---|
Bepridil enhances in vitro antitumor activity of antiestrogens in human brain tumor cells.
Topics: Bepridil; Brain Neoplasms; Calcium Channel Blockers; Cell Division; Clomiphene; Drug Synergism; Estr | 1996 |